Journal Article Summary
The article investigates the prevalence and implications of drug-drug interactions (DDIs), specifically focusing on the combination of tizanidine and ciprofloxacin, which is known to be contraindicated. Understanding DDIs is crucial because they can lead to adverse drug events, increased hospitalizations, and additional healthcare visits, which ultimately affect patient safety and healthcare costs. This study aims to analyze these interactions on a larger population level using Swiss claims data, highlighting the need for awareness and management of potentially harmful drug combinations.
The researchers analyzed anonymized claims data from over 524,000 patients in Switzerland during 2014-2015. They identified the frequency of contraindicated and major interactions and conducted a cohort study comparing patients prescribed both tizanidine and ciprofloxacin with those taking tizanidine and other antibiotics. The findings revealed that the combination of tizanidine and ciprofloxacin was associated with a significant increase in outpatient physician visits within 14 and 30 days after starting the antibiotic, as well as a trend toward increased hospitalization risk, although the latter was not statistically significant.
However, the study has limitations, including the reliance on prescription data without confirming actual medication intake, which may lead to an underestimation of interactions. Additionally, the lack of information on over-the-counter medications and the absence of specific diagnoses for hospitalizations or visits could affect the results. Patients should discuss any concerns about potential drug interactions with their healthcare providers, especially if they are prescribed multiple medications, to ensure safe and effective treatment plans.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Jödicke Annika M., Curkovic Ivanka, Zellweger Urs, Tomka Ivan T., Neuer Thomas, Kullak-Ublick Gerd A., Roos Malgorzata, Egbring Marco. Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated Combination. The Annals of Pharmacotherapy 2018. DOI: 10.1177/1060028018775914. PMID: 29749261. PMCID: PMC6136070.
Featured Pill Pals Product
Tizanidine 2 mg Capsules --- Generic For Zanaflex --- Ascend
Tizanidine 2 mg Capsules — Generic For Zanaflex — Ascend is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
